// App-Quantinova.ai

1623 : A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Researchers

Presenter

  • Sarah Larson

Principal Investigators

  • Kathryn Trinkaus

  • Nancy L. Bartlett

  • Marilyn J. Siegel

  • David D. Hurd

  • Kristie A. Blum

  • Andre Goy

  • Timothy S. Fenske

  • Amanda Cashen

  • Nina D. Wagner-Johnston

  • Kenneth R. Carson

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hodgkin's Lymphoma

  • Alpha-thalassemia myelodysplasia syndrome

  • Venous thrombosis

  • Multiple Myeloma

  • Thrombocytopenia

  • Myelodysplastic Syndrome

  • Neutropenia

  • Lymphomas

  • Anemia

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

Drug/Treatment

  • Lenalidomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved